| Gene symbol |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
AK157575
|  |
AK157575 |
activated spleen cDNA, RIKEN full-length enriched library, clone:F830224H04 product:unclassifiable, full insert sequence. [AK157575] |
KLA | .73 |
.72 |
.68 |
.76 |
.91 |
.91 |
1.02 |
| ATP | 2.85 |
3.50 |
5.51 |
5.90 |
1.67 |
.96 |
.94 |
| KLA/ATP | 1.11 |
1.56 |
2.49 |
2.64 |
1.45 |
1.05 |
.95 |
|
| Abat |  |
AK083062 |
12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530041H11 product:hypothetical protein, full insert sequence. [AK083062] |
KLA | 1.01 |
1.09 |
.97 |
.99 |
1.03 |
1.02 |
1.06 |
| ATP | .96 |
.99 |
1.00 |
1.11 |
1.04 |
.98 |
1.06 |
| KLA/ATP | 1.06 |
1.03 |
.96 |
1.06 |
1.10 |
1.06 |
.96 |
|
| Abat | |
NM_172961 |
4-aminobutyrate aminotransferase (Abat), nuclear gene encoding mitochondrial protein, mRNA [NM_172961] |
KLA | 1.03 |
.96 |
.97 |
1.00 |
.92 |
.97 |
.96 |
| ATP | .97 |
.93 |
1.07 |
1.04 |
.97 |
.99 |
.98 |
| KLA/ATP | 1.03 |
1.01 |
1.00 |
.98 |
.94 |
.89 |
.97 |
|
| Adcy1 |  |
BC050125 |
adenylate cyclase 1, mRNA (cDNA clone IMAGE:30015692). [BC050125] |
KLA | 1.05 |
1.03 |
.98 |
1.04 |
1.05 |
1.09 |
1.10 |
| ATP | .90 |
1.02 |
.99 |
.97 |
1.03 |
.95 |
1.01 |
| KLA/ATP | .99 |
1.04 |
.90 |
.98 |
.98 |
1.00 |
1.03 |
|
| Adcy1 | |
NM_009622 |
adenylate cyclase 1 (Adcy1), mRNA [NM_009622] |
KLA | 1.07 |
1.02 |
1.06 |
1.07 |
1.03 |
1.02 |
1.01 |
| ATP | 1.02 |
1.04 |
1.00 |
.99 |
.99 |
.95 |
.97 |
| KLA/ATP | .97 |
1.05 |
1.02 |
1.05 |
1.01 |
.98 |
1.05 |
|
| Adcy2 |  |
NM_153534 |
adenylate cyclase 2 (Adcy2), mRNA [NM_153534] |
KLA | .79 |
.82 |
.83 |
.73 |
.61 |
.66 |
.90 |
| ATP | 1.10 |
1.09 |
1.02 |
1.04 |
.88 |
.58 |
.53 |
| KLA/ATP | .84 |
.87 |
.77 |
.75 |
.68 |
.60 |
.43 |
|
| Adcy3 |  |
NM_138305 |
adenylate cyclase 3 (Adcy3), mRNA [NM_138305] |
KLA | .84 |
.84 |
.83 |
.78 |
.66 |
.55 |
.49 |
| ATP | 1.09 |
1.05 |
.89 |
1.02 |
.84 |
.62 |
1.52 |
| KLA/ATP | .93 |
.87 |
.75 |
.85 |
.66 |
.83 |
.77 |
|
| Adcy4 |  |
NM_080435 |
adenylate cyclase 4 (Adcy4), mRNA [NM_080435] |
KLA | 1.05 |
1.07 |
.96 |
1.00 |
1.04 |
1.05 |
1.05 |
| ATP | 1.02 |
1.05 |
1.02 |
1.48 |
1.37 |
1.08 |
1.09 |
| KLA/ATP | 1.00 |
1.05 |
.91 |
1.19 |
1.35 |
1.27 |
1.08 |
|
| Adcy5 |  |
NM_001012765 |
adenylate cyclase 5 (Adcy5), mRNA [NM_001012765] |
KLA | 1.06 |
1.00 |
.97 |
1.01 |
1.03 |
.95 |
.93 |
| ATP | .95 |
1.08 |
1.08 |
1.07 |
.97 |
1.03 |
.97 |
| KLA/ATP | .97 |
.92 |
1.04 |
.99 |
.91 |
.96 |
1.04 |
|
| Adcy6 |  |
NM_007405 |
adenylate cyclase 6 (Adcy6), mRNA [NM_007405] |
KLA | 1.10 |
1.16 |
1.16 |
1.09 |
1.08 |
1.06 |
.99 |
| ATP | 1.05 |
.97 |
1.08 |
1.12 |
1.08 |
1.08 |
1.04 |
| KLA/ATP | 1.14 |
1.20 |
1.29 |
1.30 |
1.25 |
1.11 |
1.07 |
|
| Adcy7 |  |
NM_001037724 |
adenylate cyclase 7 (Adcy7), transcript variant 3, mRNA [NM_001037724] |
KLA | .43 |
.39 |
.35 |
.32 |
.45 |
.72 |
.84 |
| ATP | .90 |
.84 |
.62 |
.41 |
.53 |
.42 |
.94 |
| KLA/ATP | .39 |
.34 |
.23 |
.17 |
.41 |
.34 |
.67 |
|
| Adcy7 | |
NM_007406 |
adenylate cyclase 7 (Adcy7), transcript variant 1, mRNA [NM_007406] |
KLA | .51 |
.52 |
.48 |
.41 |
.59 |
.81 |
.99 |
| ATP | 1.01 |
1.02 |
.62 |
.52 |
.53 |
.38 |
.98 |
| KLA/ATP | .53 |
.48 |
.30 |
.27 |
.42 |
.36 |
.65 |
|
| Adcy8 |  |
NM_009623 |
adenylate cyclase 8 (Adcy8), mRNA [NM_009623] |
KLA | 1.00 |
1.00 |
1.07 |
.97 |
1.04 |
.98 |
1.02 |
| ATP | 1.04 |
1.05 |
1.14 |
1.03 |
.99 |
1.00 |
.97 |
| KLA/ATP | 1.05 |
1.04 |
1.00 |
1.03 |
.98 |
.94 |
.96 |
|
| Adcy9 |  |
NM_009624 |
adenylate cyclase 9 (Adcy9), mRNA [NM_009624] |
KLA | .18 |
.15 |
.13 |
.15 |
.17 |
.19 |
.33 |
| ATP | 1.33 |
1.16 |
.97 |
.98 |
.62 |
.56 |
.86 |
| KLA/ATP | .19 |
.16 |
.17 |
.18 |
.20 |
.25 |
.38 |
|
| Cacna1a |  |
NM_007578 |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (Cacna1a), mRNA [NM_007578] |
KLA | .71 |
.66 |
.61 |
.63 |
.60 |
.71 |
.72 |
| ATP | 1.07 |
1.04 |
.89 |
1.08 |
.71 |
.56 |
.75 |
| KLA/ATP | .71 |
.72 |
.85 |
.69 |
.64 |
.63 |
.68 |
|
| Cacna1b |  |
U04999 |
N-type calcium channel alpha1 subunit mRNA, complete cds [U04999] |
KLA | .94 |
.94 |
.95 |
.88 |
1.09 |
.85 |
.92 |
| ATP | 1.06 |
1.17 |
1.00 |
1.24 |
1.59 |
1.15 |
1.17 |
| KLA/ATP | .91 |
.91 |
.95 |
.95 |
.90 |
.97 |
1.01 |
|
| Cacna1d |  |
NM_001083616 |
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 2, mRNA [NM_001083616] |
KLA | 1.57 |
1.58 |
2.50 |
3.62 |
4.55 |
2.93 |
.99 |
| ATP | 1.12 |
.99 |
.97 |
.94 |
.75 |
1.71 |
1.48 |
| KLA/ATP | 1.47 |
1.51 |
1.82 |
1.56 |
1.67 |
2.93 |
4.60 |
|
| Cacna1d | |
NM_028981 |
calcium channel, voltage-dependent, L type, alpha 1D subunit (Cacna1d), transcript variant 1, mRNA [NM_028981] |
KLA | 1.20 |
1.26 |
1.43 |
1.62 |
2.07 |
1.66 |
1.00 |
| ATP | 1.03 |
1.03 |
.97 |
.97 |
.93 |
1.20 |
1.26 |
| KLA/ATP | 1.16 |
1.12 |
1.10 |
1.14 |
1.08 |
1.44 |
2.56 |
|
| Cacna1f |  |
NM_019582 |
calcium channel, voltage-dependent, alpha 1F subunit (Cacna1f), mRNA [NM_019582] |
KLA | 1.03 |
.98 |
1.05 |
1.06 |
1.00 |
1.02 |
1.01 |
| ATP | 1.05 |
1.05 |
.95 |
.98 |
.97 |
.96 |
1.01 |
| KLA/ATP | 1.01 |
1.03 |
.94 |
1.01 |
1.01 |
1.00 |
.99 |
|
| Cacna1s |  |
NM_001081023 |
calcium channel, voltage-dependent, L type, alpha 1S subunit (Cacna1s), mRNA [NM_001081023] |
KLA | 1.03 |
1.01 |
.96 |
1.06 |
1.00 |
1.00 |
1.05 |
| ATP | 1.01 |
.98 |
1.02 |
1.02 |
1.05 |
1.07 |
1.05 |
| KLA/ATP | .99 |
1.05 |
1.02 |
1.05 |
1.03 |
1.05 |
1.00 |
|
| Gabarap |  |
NM_019749 |
gamma-aminobutyric acid receptor associated protein (Gabarap), mRNA [NM_019749] |
KLA | .93 |
.88 |
.95 |
.99 |
1.07 |
1.06 |
1.22 |
| ATP | 1.22 |
1.27 |
.95 |
1.38 |
1.44 |
1.25 |
1.51 |
| KLA/ATP | 1.02 |
1.11 |
.86 |
1.30 |
1.17 |
1.49 |
2.13 |
|
Gabarapl
1 |  |
NM_020590 |
gamma-aminobutyric acid (GABA(A)) receptor-associated protein-like 1 (Gabarapl1), mRNA [NM_020590] |
KLA | .68 |
.67 |
.64 |
.55 |
.50 |
.58 |
.81 |
| ATP | 1.03 |
1.09 |
1.28 |
1.46 |
3.14 |
3.86 |
.91 |
| KLA/ATP | .69 |
.75 |
.80 |
.92 |
1.74 |
2.32 |
1.07 |
|
Gabarapl
2 |  |
AK049819 |
adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630001N14 product:GABA(A) receptor-associated protein like 2, full insert sequence [AK049819] |
KLA | .92 |
.94 |
.93 |
.95 |
.85 |
.85 |
.86 |
| ATP | .98 |
1.03 |
1.17 |
1.18 |
1.19 |
1.04 |
.86 |
| KLA/ATP | .98 |
1.04 |
1.09 |
1.03 |
1.06 |
.91 |
.87 |
|
| Gabbr1 |  |
NM_019439 |
gamma-aminobutyric acid (GABA-B) receptor, 1 (Gabbr1), mRNA [NM_019439] |
KLA | 1.00 |
1.03 |
1.04 |
1.01 |
.97 |
1.01 |
.99 |
| ATP | .98 |
.96 |
1.03 |
1.01 |
.96 |
1.03 |
.99 |
| KLA/ATP | .97 |
1.00 |
.97 |
1.02 |
1.02 |
.97 |
1.01 |
|
| Gabbr2 |  |
NM_001081141 |
gamma-aminobutyric acid (GABA) B receptor 2 (Gabbr2), mRNA [NM_001081141] |
KLA | 1.06 |
.98 |
.99 |
1.03 |
1.09 |
1.06 |
1.02 |
| ATP | 1.03 |
1.06 |
1.05 |
1.14 |
1.10 |
1.00 |
1.04 |
| KLA/ATP | 1.09 |
1.10 |
1.12 |
1.11 |
1.06 |
1.04 |
1.06 |
|
| Gabra1 |  |
NM_010250 |
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1 (Gabra1), mRNA [NM_010250] |
KLA | 1.01 |
.99 |
1.01 |
1.06 |
1.00 |
1.07 |
1.04 |
| ATP | 1.03 |
1.04 |
1.07 |
1.05 |
1.02 |
.99 |
.99 |
| KLA/ATP | 1.05 |
1.02 |
1.04 |
1.06 |
1.05 |
1.06 |
1.01 |
|
| Gabra2 |  |
AK048165 |
16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130038H23 product:gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2, full insert sequence [AK048165] |
KLA | .98 |
1.06 |
1.03 |
1.01 |
1.03 |
1.03 |
.98 |
| ATP | 1.00 |
1.00 |
1.05 |
1.07 |
.96 |
.92 |
1.04 |
| KLA/ATP | 1.02 |
1.09 |
.97 |
1.02 |
.99 |
.98 |
.80 |
|
| Gabra2 | |
NM_008066 |
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2 (Gabra2), mRNA [NM_008066] |
KLA | .99 |
1.01 |
1.10 |
1.05 |
.96 |
.93 |
.98 |
| ATP | 1.09 |
.99 |
.99 |
.98 |
.97 |
.93 |
.94 |
| KLA/ATP | .99 |
.97 |
.97 |
.96 |
1.02 |
.97 |
1.04 |
|
| Gabra3 |  |
NM_008067 |
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 (Gabra3), mRNA [NM_008067] |
KLA | 1.00 |
1.01 |
1.03 |
.99 |
1.01 |
1.00 |
1.01 |
| ATP | 1.03 |
.97 |
1.03 |
.98 |
.98 |
.97 |
1.00 |
| KLA/ATP | .99 |
1.08 |
1.05 |
.98 |
1.00 |
1.03 |
.96 |
|
| Gabra4 |  |
NM_010251 |
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 (Gabra4), mRNA [NM_010251] |
KLA | .98 |
1.01 |
1.02 |
.99 |
1.03 |
.95 |
1.02 |
| ATP | .98 |
.94 |
1.03 |
1.09 |
1.00 |
1.06 |
1.03 |
| KLA/ATP | 1.04 |
1.00 |
1.02 |
.97 |
1.02 |
1.05 |
.98 |
|
| Gabra5 |  |
NM_176942 |
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 (Gabra5), mRNA [NM_176942] |
KLA | .97 |
.92 |
1.00 |
.97 |
1.01 |
.99 |
.97 |
| ATP | 1.02 |
.99 |
1.03 |
.98 |
1.00 |
.98 |
1.00 |
| KLA/ATP | .97 |
.99 |
1.01 |
1.00 |
.97 |
.97 |
.92 |
|
| Gabra6 |  |
NM_008068 |
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 (Gabra6), transcript variant 2, mRNA [NM_008068] |
KLA | 1.05 |
1.02 |
.96 |
1.06 |
.96 |
1.02 |
1.07 |
| ATP | 1.01 |
.96 |
1.03 |
1.00 |
.99 |
.94 |
1.07 |
| KLA/ATP | .99 |
.99 |
1.09 |
1.01 |
1.13 |
.97 |
1.07 |
|
| Gabrb1 |  |
NM_008069 |
gamma-aminobutyric acid (GABA-A) receptor, subunit beta 1 (Gabrb1), mRNA [NM_008069] |
KLA | .99 |
.98 |
.99 |
1.00 |
1.02 |
.99 |
.95 |
| ATP | 1.00 |
1.04 |
.98 |
1.01 |
1.05 |
1.02 |
1.03 |
| KLA/ATP | 1.00 |
.96 |
1.00 |
.96 |
1.05 |
1.03 |
1.04 |
|
| Gabrb2 |  |
NM_008070 |
gamma-aminobutyric acid (GABA-A) receptor, subunit beta 2 (Gabrb2), mRNA [NM_008070] |
KLA | 1.04 |
1.04 |
1.03 |
1.04 |
1.00 |
.98 |
1.03 |
| ATP | .99 |
1.01 |
1.00 |
1.01 |
1.03 |
.99 |
.93 |
| KLA/ATP | 1.05 |
1.06 |
1.05 |
.96 |
.97 |
.94 |
1.00 |
|
| Gabrb3 |  |
NM_008071 |
gamma-aminobutyric acid (GABA-A) receptor, subunit beta 3 (Gabrb3), transcript variant 1, mRNA [NM_008071] |
KLA | .99 |
.99 |
.99 |
1.01 |
.99 |
.97 |
1.00 |
| ATP | .98 |
1.02 |
1.00 |
.99 |
.99 |
.99 |
1.00 |
| KLA/ATP | 1.00 |
1.03 |
1.05 |
.97 |
.98 |
.99 |
.99 |
|
| Gabrd |  |
NM_008072 |
gamma-aminobutyric acid (GABA-A) receptor, subunit delta (Gabrd), mRNA [NM_008072] |
KLA | 1.36 |
1.25 |
1.30 |
1.25 |
1.16 |
1.42 |
1.07 |
| ATP | .97 |
.82 |
.91 |
.80 |
.74 |
1.02 |
.96 |
| KLA/ATP | 1.12 |
1.10 |
1.06 |
.87 |
.89 |
1.04 |
1.12 |
|
| Gabre |  |
NM_017369 |
gamma-aminobutyric acid (GABA-A) receptor, subunit epsilon (Gabre), mRNA [NM_017369] |
KLA | .97 |
1.04 |
.98 |
1.01 |
1.03 |
.99 |
1.05 |
| ATP | .96 |
1.00 |
.96 |
1.04 |
.98 |
.99 |
1.02 |
| KLA/ATP | 1.00 |
1.02 |
1.01 |
.97 |
.93 |
.93 |
.89 |
|
| Gabrg1 |  |
AK038686 |
adult male hypothalamus cDNA, RIKEN full-length enriched library, clone:A230055A07 product:gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1, full insert sequence. [AK038686] |
KLA | .98 |
1.06 |
1.09 |
1.00 |
1.01 |
1.05 |
1.07 |
| ATP | .96 |
.99 |
1.03 |
1.03 |
1.03 |
1.00 |
1.08 |
| KLA/ATP | 1.04 |
1.04 |
.90 |
1.04 |
1.04 |
1.08 |
1.07 |
|
| Gabrg1 | |
NM_010252 |
gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1 (Gabrg1), mRNA [NM_010252] |
KLA | 1.00 |
1.00 |
.98 |
.99 |
1.01 |
1.01 |
1.01 |
| ATP | 1.00 |
.99 |
1.00 |
1.03 |
1.01 |
1.02 |
1.01 |
| KLA/ATP | .98 |
.98 |
1.00 |
1.00 |
1.00 |
1.00 |
1.02 |
|
| Gabrg2 |  |
NM_008073 |
gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2 (Gabrg2), transcript variant 1, mRNA [NM_008073] |
KLA | 1.04 |
1.03 |
1.03 |
.97 |
.99 |
.98 |
1.03 |
| ATP | .97 |
1.00 |
1.05 |
1.00 |
1.01 |
1.01 |
1.01 |
| KLA/ATP | 1.01 |
.94 |
1.04 |
1.06 |
1.01 |
.95 |
1.02 |
|
| Gabrg3 |  |
NM_008074 |
gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 3 (Gabrg3), mRNA [NM_008074] |
KLA | .98 |
1.03 |
1.01 |
1.05 |
1.01 |
1.08 |
1.09 |
| ATP | 1.04 |
1.09 |
1.02 |
1.06 |
1.07 |
1.05 |
1.06 |
| KLA/ATP | 1.01 |
1.14 |
1.07 |
1.04 |
1.04 |
1.15 |
1.01 |
|
| Gabrp |  |
NM_146017 |
gamma-aminobutyric acid (GABA-A) receptor, pi (Gabrp), mRNA [NM_146017] |
KLA | 1.03 |
.97 |
.99 |
1.08 |
.98 |
1.08 |
1.00 |
| ATP | .95 |
1.04 |
1.03 |
.95 |
.95 |
.95 |
1.05 |
| KLA/ATP | .97 |
.98 |
.98 |
.98 |
.95 |
.94 |
.86 |
|
| Gabrq |  |
NM_020488 |
gamma-aminobutyric acid (GABA-A) receptor, subunit theta (Gabrq), mRNA [NM_020488] |
KLA | 1.00 |
.97 |
1.04 |
1.02 |
1.02 |
.88 |
.96 |
| ATP | 1.03 |
1.03 |
.99 |
.94 |
1.05 |
.94 |
.90 |
| KLA/ATP | .94 |
1.00 |
1.03 |
.93 |
.98 |
1.01 |
1.01 |
|
| Gabrr1 |  |
NM_008075 |
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 (Gabrr1), mRNA [NM_008075] |
KLA | 1.37 |
1.28 |
1.42 |
1.45 |
1.28 |
1.19 |
1.01 |
| ATP | .99 |
1.01 |
1.30 |
1.10 |
1.13 |
1.05 |
.80 |
| KLA/ATP | 1.25 |
1.36 |
1.40 |
1.29 |
1.16 |
1.00 |
.79 |
|
| Gabrr2 |  |
NM_008076 |
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 (Gabrr2), mRNA [NM_008076] |
KLA | 1.03 |
1.04 |
.99 |
1.02 |
1.05 |
.98 |
1.12 |
| ATP | 1.07 |
.98 |
1.00 |
1.08 |
1.04 |
.97 |
1.02 |
| KLA/ATP | 1.04 |
1.00 |
.94 |
.99 |
1.05 |
1.05 |
1.05 |
|
| Gad1 |  |
AK054554 |
10 days neonate olfactory brain cDNA, RIKEN full-length enriched library, clone:E530004P22 product:glutamic acid decarboxylase 1, full insert sequence. [AK054554] |
KLA | 1.03 |
1.00 |
1.00 |
1.00 |
1.00 |
.98 |
1.10 |
| ATP | 1.03 |
.91 |
1.01 |
1.05 |
.99 |
.97 |
1.08 |
| KLA/ATP | .97 |
.99 |
.99 |
1.10 |
1.02 |
1.09 |
.96 |
|
| Gad1 | |
NM_008077 |
glutamic acid decarboxylase 1 (Gad1), mRNA [NM_008077] |
KLA | 1.03 |
.99 |
1.00 |
1.01 |
1.01 |
.97 |
.99 |
| ATP | 1.02 |
1.02 |
1.01 |
.99 |
1.02 |
1.03 |
.98 |
| KLA/ATP | .96 |
1.03 |
1.04 |
.99 |
.99 |
1.04 |
1.01 |
|
| Gad2 |  |
NM_008078 |
glutamic acid decarboxylase 2 (Gad2), mRNA [NM_008078] |
KLA | 1.03 |
1.07 |
1.11 |
1.11 |
1.04 |
.99 |
1.07 |
| ATP | .97 |
.99 |
1.02 |
1.02 |
1.01 |
.95 |
.97 |
| KLA/ATP | 1.05 |
1.08 |
1.04 |
1.01 |
1.00 |
1.06 |
1.00 |
|
| Gls2 |  |
NM_001033264 |
glutaminase 2 (liver, mitochondrial) (Gls2), nuclear gene encoding mitochondrial protein, mRNA [NM_001033264] |
KLA | 1.03 |
.98 |
1.02 |
.97 |
.98 |
.88 |
.80 |
| ATP | .94 |
1.01 |
1.04 |
1.08 |
1.26 |
1.20 |
.87 |
| KLA/ATP | .95 |
.98 |
1.15 |
1.02 |
1.29 |
.99 |
.87 |
|
| Glul |  |
NM_008131 |
glutamate-ammonia ligase (glutamine synthetase) (Glul), mRNA [NM_008131] |
KLA | .58 |
.54 |
.47 |
.41 |
.30 |
.31 |
.40 |
| ATP | .96 |
.99 |
1.46 |
2.55 |
2.16 |
2.88 |
1.34 |
| KLA/ATP | .57 |
.56 |
.83 |
1.52 |
1.27 |
1.20 |
.97 |
|
| Glul | |
X16314 |
gb|M.musculus mRNA for glutamine synthetase. [X16314] |
KLA | .86 |
.95 |
.79 |
.87 |
.78 |
.99 |
.83 |
| ATP | .95 |
1.03 |
1.09 |
1.27 |
1.14 |
1.37 |
1.00 |
| KLA/ATP | .88 |
.97 |
.89 |
1.12 |
1.01 |
1.19 |
.91 |
|
| Gnai1 |  |
NM_010305 |
guanine nucleotide binding protein (G protein), alpha inhibiting 1 (Gnai1), mRNA [NM_010305] |
KLA | .95 |
1.01 |
1.01 |
1.00 |
1.09 |
1.10 |
1.08 |
| ATP | 1.06 |
1.06 |
.99 |
1.15 |
1.02 |
.94 |
.99 |
| KLA/ATP | 1.02 |
1.04 |
.99 |
1.16 |
1.01 |
1.02 |
1.13 |
|
| Gnai2 |  |
NM_008138 |
guanine nucleotide binding protein (G protein), alpha inhibiting 2 (Gnai2), mRNA [NM_008138] |
KLA | .74 |
.79 |
.82 |
.74 |
.91 |
.97 |
1.10 |
| ATP | 1.07 |
1.16 |
.78 |
1.12 |
.78 |
.48 |
.82 |
| KLA/ATP | .91 |
.81 |
.53 |
.80 |
.60 |
.68 |
.87 |
|
| Gnai3 |  |
NM_010306 |
guanine nucleotide binding protein (G protein), alpha inhibiting 3 (Gnai3), mRNA [NM_010306] |
KLA | 1.23 |
1.24 |
1.14 |
1.06 |
.99 |
1.15 |
1.09 |
| ATP | .96 |
.93 |
.86 |
.64 |
1.34 |
2.02 |
1.35 |
| KLA/ATP | 1.20 |
1.24 |
.97 |
.76 |
1.21 |
1.62 |
1.17 |
|
| Gnao1 |  |
NM_001113384 |
guanine nucleotide binding protein, alpha O (Gnao1), transcript variant B, mRNA [NM_001113384] |
KLA | .95 |
.98 |
1.03 |
1.00 |
1.02 |
1.02 |
.99 |
| ATP | .95 |
1.02 |
1.01 |
1.08 |
.99 |
.97 |
.95 |
| KLA/ATP | 1.05 |
1.04 |
1.10 |
.99 |
1.01 |
.98 |
1.03 |
|
| Gnao1 | |
NM_010308 |
guanine nucleotide binding protein, alpha O (Gnao1), transcript variant A, mRNA [NM_010308] |
KLA | .98 |
.96 |
1.00 |
.97 |
.96 |
.97 |
1.01 |
| ATP | 1.12 |
.99 |
1.05 |
.87 |
.97 |
1.02 |
1.01 |
| KLA/ATP | .93 |
1.00 |
.99 |
1.01 |
1.05 |
1.07 |
.98 |
|
| Gnb1 |  |
NM_008142 |
guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] |
KLA | 1.11 |
1.18 |
1.22 |
1.19 |
1.29 |
1.32 |
1.76 |
| ATP | 1.02 |
1.09 |
.84 |
.99 |
.97 |
.89 |
1.22 |
| KLA/ATP | 1.20 |
1.25 |
.85 |
1.01 |
.86 |
.91 |
1.57 |
|
| Gnb2 |  |
NM_010312 |
guanine nucleotide binding protein (G protein), beta 2 (Gnb2), mRNA [NM_010312] |
KLA | .94 |
.98 |
.94 |
1.08 |
1.23 |
1.32 |
1.16 |
| ATP | 1.04 |
.96 |
.59 |
.64 |
.59 |
.76 |
1.18 |
| KLA/ATP | 1.02 |
.84 |
.62 |
.64 |
.61 |
.89 |
1.36 |
|
| Gnb3 |  |
NM_013530 |
guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] |
KLA | .99 |
1.00 |
.98 |
1.03 |
.94 |
.99 |
.96 |
| ATP | 1.01 |
1.02 |
.97 |
.95 |
1.01 |
.97 |
.92 |
| KLA/ATP | .99 |
1.02 |
1.02 |
.98 |
.99 |
.85 |
.99 |
|
| Gnb4 |  |
AK165084 |
2 days pregnant adult female ovary cDNA, RIKEN full-length enriched library, clone:E330002E21 product:guanine nucleotide binding protein, beta 4, full insert sequence [AK165084] |
KLA | 4.61 |
4.10 |
4.23 |
2.41 |
2.25 |
1.59 |
.93 |
| ATP | 1.21 |
1.17 |
1.04 |
.81 |
2.92 |
1.50 |
1.03 |
| KLA/ATP | 5.86 |
6.56 |
3.60 |
1.68 |
5.62 |
3.00 |
1.37 |
|
| Gnb4 | |
NM_013531 |
guanine nucleotide binding protein (G protein), beta 4 (Gnb4), mRNA [NM_013531] |
KLA | 8.41 |
8.09 |
10.57 |
9.44 |
6.06 |
2.97 |
.92 |
| ATP | 1.07 |
1.04 |
1.09 |
.87 |
1.48 |
2.10 |
1.18 |
| KLA/ATP | 8.14 |
8.93 |
9.12 |
7.69 |
5.03 |
5.11 |
2.37 |
|
| Gnb5 |  |
NM_010313 |
guanine nucleotide binding protein (G protein), beta 5 (Gnb5), transcript variant 1, mRNA [NM_010313] |
KLA | .68 |
.75 |
.67 |
.66 |
.53 |
.50 |
.65 |
| ATP | 1.03 |
1.08 |
1.09 |
1.14 |
.72 |
.54 |
.77 |
| KLA/ATP | .73 |
.70 |
.71 |
.73 |
.61 |
.65 |
.58 |
|
| Gng10 |  |
NM_025277 |
guanine nucleotide binding protein (G protein), gamma 10 (Gng10), mRNA [NM_025277] |
KLA | .95 |
.95 |
.86 |
.83 |
.70 |
.53 |
.43 |
| ATP | .93 |
1.03 |
1.17 |
1.21 |
.97 |
.60 |
.52 |
| KLA/ATP | .84 |
.91 |
.93 |
.99 |
.79 |
.47 |
.24 |
|
| Gng11 |  |
NM_025331 |
guanine nucleotide binding protein (G protein), gamma 11 (Gng11), mRNA [NM_025331] |
KLA | 1.30 |
1.26 |
1.44 |
1.54 |
1.26 |
1.42 |
1.90 |
| ATP | .88 |
.78 |
1.26 |
1.14 |
.90 |
.64 |
1.60 |
| KLA/ATP | 1.11 |
1.18 |
1.81 |
1.55 |
1.81 |
1.75 |
3.05 |
|
| Gng12 |  |
NM_025278 |
guanine nucleotide binding protein (G protein), gamma 12 (Gng12), mRNA [NM_025278] |
KLA | 2.21 |
2.23 |
2.48 |
2.62 |
2.47 |
2.28 |
1.68 |
| ATP | 1.02 |
1.02 |
1.09 |
1.10 |
1.20 |
1.32 |
1.01 |
| KLA/ATP | 2.10 |
2.17 |
2.38 |
2.40 |
1.91 |
1.60 |
1.77 |
|
| Gng13 |  |
NM_022422 |
guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] |
KLA | 1.04 |
1.04 |
.94 |
1.00 |
1.00 |
1.05 |
.96 |
| ATP | 1.07 |
1.05 |
1.02 |
.94 |
.98 |
1.03 |
1.01 |
| KLA/ATP | 1.01 |
.99 |
1.05 |
1.01 |
1.01 |
.98 |
1.02 |
|
| Gng2 |  |
NM_010315 |
guanine nucleotide binding protein (G protein), gamma 2 (Gng2), transcript variant 1, mRNA [NM_010315] |
KLA | .79 |
.81 |
.81 |
.82 |
.67 |
.57 |
.75 |
| ATP | 1.02 |
1.01 |
1.13 |
1.35 |
1.48 |
1.01 |
1.31 |
| KLA/ATP | .79 |
.86 |
.97 |
1.05 |
1.29 |
1.00 |
.84 |
|
| Gng3 |  |
NM_010316 |
guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] |
KLA | 1.00 |
.98 |
1.02 |
.95 |
.99 |
1.00 |
1.06 |
| ATP | .98 |
1.05 |
.99 |
1.03 |
1.05 |
1.03 |
.97 |
| KLA/ATP | 1.01 |
1.00 |
1.07 |
1.01 |
1.04 |
1.04 |
1.05 |
|
| Gng4 |  |
NM_010317 |
guanine nucleotide binding protein (G protein), gamma 4 (Gng4), mRNA [NM_010317] |
KLA | 1.27 |
1.26 |
1.47 |
1.30 |
1.15 |
1.13 |
.82 |
| ATP | 1.05 |
.97 |
1.07 |
1.62 |
3.97 |
3.46 |
1.24 |
| KLA/ATP | 1.35 |
1.32 |
1.37 |
1.35 |
1.64 |
2.18 |
1.56 |
|
| Gng5 |  |
NM_010318 |
guanine nucleotide binding protein (G protein), gamma 5 (Gng5), mRNA [NM_010318] |
KLA | .94 |
.84 |
.80 |
1.12 |
.98 |
1.11 |
1.29 |
| ATP | 1.07 |
1.01 |
1.07 |
1.05 |
1.17 |
1.52 |
1.01 |
| KLA/ATP | .83 |
.94 |
1.27 |
1.17 |
1.19 |
1.35 |
1.36 |
|
| Gng7 |  |
NM_001038655 |
guanine nucleotide binding protein (G protein), gamma 7 (Gng7), transcript variant 1, mRNA [NM_001038655] |
KLA | .92 |
.96 |
.87 |
.91 |
.83 |
.98 |
.98 |
| ATP | 1.04 |
1.06 |
.98 |
.95 |
.81 |
.77 |
.75 |
| KLA/ATP | .97 |
.95 |
.81 |
.91 |
.79 |
.77 |
.81 |
|
| Gng8 |  |
NM_010320 |
guanine nucleotide binding protein (G protein), gamma 8 (Gng8), mRNA [NM_010320] |
KLA | .93 |
.93 |
.95 |
.96 |
.90 |
.88 |
1.09 |
| ATP | .95 |
.90 |
1.01 |
.92 |
1.04 |
1.01 |
1.05 |
| KLA/ATP | .97 |
1.03 |
.99 |
.90 |
1.10 |
.99 |
1.04 |
|
| Gngt1 |  |
NM_010314 |
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1 (Gngt1), mRNA [NM_010314] |
KLA | 1.06 |
.99 |
.95 |
.98 |
1.03 |
1.10 |
.98 |
| ATP | .96 |
1.02 |
1.03 |
1.03 |
.94 |
1.06 |
.95 |
| KLA/ATP | .98 |
1.03 |
1.04 |
1.04 |
1.01 |
1.03 |
1.01 |
|
| Gphn |  |
AK017831 |
8 days embryo whole body cDNA, RIKEN full-length enriched library, clone:5730552E08 product:inferred: RIKEN cDNA 5730552E08 gene, full insert sequence [AK017831] |
KLA | 1.58 |
1.60 |
1.54 |
1.20 |
1.08 |
.93 |
1.08 |
| ATP | .98 |
1.01 |
1.02 |
1.20 |
.80 |
.71 |
.78 |
| KLA/ATP | 1.69 |
1.87 |
1.62 |
1.85 |
1.13 |
.79 |
.91 |
|
| Gphn | |
NM_172952 |
gephyrin (Gphn), mRNA [NM_172952] |
KLA | 1.93 |
2.14 |
2.17 |
2.30 |
1.82 |
.98 |
1.08 |
| ATP | .98 |
1.12 |
1.12 |
1.15 |
.95 |
1.02 |
.81 |
| KLA/ATP | 1.89 |
2.07 |
2.14 |
2.08 |
1.52 |
.98 |
.94 |
|
| Hap1 |  |
NM_010404 |
huntingtin-associated protein 1 (Hap1), mRNA [NM_010404] |
KLA | 2.10 |
2.03 |
2.71 |
2.59 |
2.99 |
2.38 |
1.20 |
| ATP | .96 |
.96 |
1.41 |
1.39 |
1.63 |
1.82 |
1.21 |
| KLA/ATP | 2.02 |
2.21 |
2.73 |
2.75 |
3.07 |
2.77 |
1.98 |
|
| Kcnj6 |  |
NM_001025585 |
potassium inwardly-rectifying channel, subfamily J, member 6 (Kcnj6), transcript variant Girk2B, mRNA [NM_001025585] |
KLA | .97 |
.96 |
.95 |
.96 |
.98 |
.96 |
.95 |
| ATP | 1.00 |
.98 |
1.02 |
1.00 |
.98 |
.96 |
.97 |
| KLA/ATP | .98 |
.95 |
.99 |
.96 |
.98 |
.93 |
.96 |
|
| Kcnj6 | |
NM_010606 |
potassium inwardly-rectifying channel, subfamily J, member 6 (Kcnj6), transcript variant Girk2A-1, mRNA [NM_010606] |
KLA | .96 |
1.03 |
.97 |
.98 |
.97 |
.99 |
1.07 |
| ATP | 1.08 |
.99 |
.99 |
1.05 |
.96 |
1.04 |
.97 |
| KLA/ATP | 1.01 |
.92 |
1.03 |
1.03 |
1.04 |
1.03 |
1.08 |
|
Mm.19418
3 |  |
82879023 |
Unknown |
KLA | 2.30 |
2.08 |
1.50 |
1.10 |
.91 |
.84 |
.68 |
| ATP | .98 |
.92 |
1.09 |
1.04 |
1.56 |
1.73 |
.87 |
| KLA/ATP | 2.07 |
2.14 |
1.87 |
1.24 |
1.31 |
1.17 |
.76 |
|
Mm.29656
0 |  |
34328321 |
Unknown |
KLA | 1.41 |
1.37 |
1.50 |
1.48 |
1.35 |
1.43 |
1.21 |
| ATP | 1.00 |
1.08 |
1.22 |
1.42 |
1.23 |
1.22 |
1.23 |
| KLA/ATP | 1.41 |
1.48 |
1.57 |
1.61 |
1.50 |
1.56 |
1.51 |
|
Mm.30102
|  |
142348692 |
Unknown |
KLA | 1.04 |
1.04 |
.97 |
1.07 |
1.02 |
.93 |
.90 |
| ATP | 1.06 |
.98 |
1.13 |
1.06 |
1.30 |
1.19 |
.78 |
| KLA/ATP | .94 |
1.05 |
1.13 |
1.05 |
1.24 |
1.12 |
.84 |
|
Mm.41137
|  |
148747308 |
Unknown |
KLA | 1.03 |
1.00 |
.95 |
.92 |
1.04 |
.98 |
.96 |
| ATP | 1.02 |
.98 |
.98 |
.90 |
.95 |
.92 |
1.07 |
| KLA/ATP | .91 |
.89 |
1.01 |
.95 |
1.00 |
.96 |
.99 |
|
Mm.44046
5 |  |
164607131 |
Unknown |
KLA | .65 |
.56 |
.59 |
.51 |
.33 |
.20 |
.24 |
| ATP | 1.07 |
.90 |
1.30 |
2.88 |
3.61 |
4.46 |
1.07 |
| KLA/ATP | .60 |
.59 |
.95 |
2.38 |
2.99 |
2.31 |
.37 |
|
Mm.44050
5 |  |
84579905 |
Unknown |
KLA | 1.03 |
.96 |
.90 |
1.03 |
.94 |
1.15 |
1.23 |
| ATP | .88 |
.91 |
1.15 |
1.18 |
1.17 |
1.31 |
1.02 |
| KLA/ATP | .87 |
.97 |
1.19 |
1.18 |
1.36 |
1.34 |
1.25 |
|
| Mm.4424 |  |
110225367 |
Unknown |
KLA | .99 |
.93 |
1.01 |
1.02 |
1.00 |
.92 |
1.00 |
| ATP | .98 |
1.03 |
3.11 |
1.13 |
1.19 |
1.03 |
1.11 |
| KLA/ATP | .95 |
.97 |
.97 |
.96 |
.93 |
1.01 |
.99 |
|
| Nsf |  |
NM_008740 |
N-ethylmaleimide sensitive fusion protein (Nsf), mRNA [NM_008740] |
KLA | .84 |
.83 |
.76 |
.70 |
.78 |
.80 |
.94 |
| ATP | 1.14 |
1.15 |
.99 |
1.08 |
.95 |
.96 |
1.19 |
| KLA/ATP | .93 |
.90 |
.80 |
.85 |
.72 |
.80 |
1.17 |
|
| Plcl1 |  |
AK048715 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230017K02 product:similar to CDNA FLJ13484 FIS, CLONE PLACE1003888, WEAKLY SIMILAR TO 1-PHOSPHATIDYLINOSITOL-4,5-BISPHOSPHATE PHOSPHODIESTERASE DELTA 1 (EC 3.1.4.11 |
KLA | .93 |
.91 |
.90 |
.86 |
.92 |
.93 |
1.00 |
| ATP | .95 |
1.04 |
.91 |
.84 |
.84 |
.83 |
.80 |
| KLA/ATP | .97 |
.92 |
.93 |
.88 |
.79 |
.76 |
.73 |
|
| Prkaca |  |
NM_008854 |
protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] |
KLA | .71 |
.74 |
.72 |
.70 |
.72 |
.84 |
.85 |
| ATP | 1.05 |
.98 |
.89 |
.92 |
.76 |
.60 |
1.02 |
| KLA/ATP | .79 |
.74 |
.55 |
.65 |
.60 |
.65 |
.93 |
|
| Prkacb |  |
NM_011100 |
protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] |
KLA | .69 |
.70 |
.66 |
.58 |
.51 |
.55 |
.59 |
| ATP | 1.02 |
1.19 |
.97 |
1.01 |
.69 |
.38 |
.56 |
| KLA/ATP | .72 |
.73 |
.57 |
.62 |
.47 |
.41 |
.45 |
|
| Prkca |  |
NM_011101 |
protein kinase C, alpha (Prkca), mRNA [NM_011101] |
KLA | 1.00 |
.96 |
.94 |
.95 |
.95 |
.89 |
.96 |
| ATP | 1.00 |
1.03 |
.91 |
.94 |
.82 |
.87 |
1.13 |
| KLA/ATP | 1.02 |
.95 |
.91 |
.86 |
.78 |
.84 |
.94 |
|
| Prkcb1 |  |
NM_008855 |
protein kinase C, beta 1 (Prkcb1), mRNA [NM_008855] |
KLA | .92 |
.95 |
.93 |
.78 |
.77 |
1.08 |
1.83 |
| ATP | 1.03 |
1.12 |
1.09 |
1.23 |
.90 |
2.08 |
.96 |
| KLA/ATP | .98 |
.99 |
.82 |
.89 |
.62 |
1.01 |
1.08 |
|
| Prkcc |  |
NM_011102 |
protein kinase C, gamma (Prkcc), mRNA [NM_011102] |
KLA | 1.02 |
1.04 |
1.11 |
1.04 |
.96 |
1.02 |
1.05 |
| ATP | .98 |
.98 |
1.05 |
1.03 |
1.08 |
.96 |
.95 |
| KLA/ATP | 1.21 |
1.16 |
1.09 |
1.07 |
1.04 |
.98 |
.93 |
|
| Prkx |  |
NM_016979 |
protein kinase, X-linked (Prkx), mRNA [NM_016979] |
KLA | 3.61 |
3.79 |
4.67 |
4.66 |
4.85 |
4.19 |
1.43 |
| ATP | .98 |
.90 |
.63 |
.61 |
1.12 |
1.90 |
1.29 |
| KLA/ATP | 3.56 |
3.36 |
2.62 |
2.06 |
2.26 |
2.87 |
2.31 |
|
| Slc12a5 |  |
NM_020333 |
solute carrier family 12, member 5 (Slc12a5), mRNA [NM_020333] |
KLA | 1.01 |
.99 |
.97 |
.99 |
.94 |
1.03 |
1.36 |
| ATP | .92 |
.87 |
1.25 |
1.10 |
.81 |
.69 |
1.01 |
| KLA/ATP | .87 |
.97 |
1.22 |
1.01 |
1.06 |
.70 |
.78 |
|
| Slc32a1 |  |
NM_009508 |
solute carrier family 32 (GABA vesicular transporter), member 1 (Slc32a1), mRNA [NM_009508] |
KLA | 1.11 |
1.01 |
1.06 |
1.10 |
1.07 |
1.05 |
1.04 |
| ATP | 1.03 |
.97 |
1.11 |
1.10 |
1.52 |
1.52 |
1.08 |
| KLA/ATP | 1.10 |
1.12 |
1.09 |
1.17 |
1.36 |
1.50 |
1.10 |
|
| Slc38a1 |  |
AK162429 |
12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430020E10 product:hypothetical protein, full insert sequence [AK162429] |
KLA | .93 |
.80 |
.66 |
.47 |
.37 |
.57 |
.84 |
| ATP | .92 |
.84 |
.94 |
1.58 |
1.58 |
.90 |
.50 |
| KLA/ATP | .87 |
.70 |
.62 |
.86 |
1.20 |
.96 |
.52 |
|
| Slc38a1 | |
NM_134086 |
solute carrier family 38, member 1 (Slc38a1), mRNA [NM_134086] |
KLA | 1.24 |
1.07 |
1.03 |
.84 |
.66 |
.71 |
.91 |
| ATP | .90 |
.83 |
1.17 |
1.64 |
1.92 |
1.39 |
.90 |
| KLA/ATP | 1.12 |
1.02 |
1.20 |
1.25 |
1.65 |
1.27 |
.99 |
|
| Slc38a2 |  |
AK164568 |
13 days embryo heart cDNA, RIKEN full-length enriched library, clone:D330050A21 product:solute carrier family 38, member 2, full insert sequence [AK164568] |
KLA | .49 |
.44 |
.31 |
.39 |
.58 |
.67 |
.87 |
| ATP | 1.52 |
1.82 |
5.27 |
8.64 |
3.25 |
1.48 |
1.13 |
| KLA/ATP | .47 |
.68 |
1.28 |
2.77 |
2.02 |
.86 |
.76 |
|
| Slc38a2 | |
NM_175121 |
solute carrier family 38, member 2 (Slc38a2), mRNA [NM_175121] |
KLA | .45 |
.46 |
.38 |
.34 |
.33 |
.52 |
.73 |
| ATP | 1.04 |
1.22 |
1.93 |
5.44 |
5.96 |
3.34 |
1.39 |
| KLA/ATP | .45 |
.48 |
.58 |
1.67 |
2.62 |
1.71 |
.86 |
|
| Slc38a3 |  |
NM_023805 |
solute carrier family 38, member 3 (Slc38a3), mRNA [NM_023805] |
KLA | 1.18 |
1.02 |
1.01 |
1.03 |
1.04 |
1.04 |
.99 |
| ATP | 1.01 |
.98 |
1.11 |
1.06 |
.99 |
1.05 |
1.06 |
| KLA/ATP | 1.02 |
1.03 |
1.15 |
1.07 |
1.04 |
.96 |
1.06 |
|
| Slc38a5 |  |
NM_172479 |
solute carrier family 38, member 5 (Slc38a5), mRNA [NM_172479] |
KLA | 1.00 |
.96 |
.98 |
.96 |
1.02 |
1.04 |
1.06 |
| ATP | .99 |
1.02 |
1.06 |
1.07 |
1.01 |
1.04 |
1.04 |
| KLA/ATP | 1.04 |
1.00 |
1.04 |
1.06 |
1.12 |
1.04 |
1.07 |
|
| Slc6a1 |  |
NM_178703 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 1 (Slc6a1), mRNA [NM_178703] |
KLA | 1.02 |
.93 |
1.06 |
1.00 |
.99 |
.96 |
1.01 |
| ATP | 1.03 |
.95 |
.94 |
.93 |
.97 |
.97 |
.98 |
| KLA/ATP | 1.02 |
1.10 |
.93 |
1.01 |
1.08 |
1.02 |
.92 |
|
| Slc6a13 |  |
NM_144512 |
solute carrier family 6 (neurotransmitter transporter, GABA), member 13 (Slc6a13), mRNA [NM_144512] |
KLA | 1.04 |
1.02 |
1.01 |
1.02 |
1.08 |
1.21 |
2.95 |
| ATP | .99 |
1.00 |
1.02 |
1.08 |
1.02 |
1.17 |
2.70 |
| KLA/ATP | 1.11 |
1.04 |
1.06 |
1.20 |
1.32 |
1.28 |
3.01 |
|
| Src |  |
NM_009271 |
Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] |
KLA | 6.99 |
7.23 |
7.54 |
5.99 |
5.34 |
3.39 |
3.00 |
| ATP | 1.02 |
1.06 |
1.06 |
2.08 |
4.41 |
5.03 |
3.97 |
| KLA/ATP | 7.44 |
7.51 |
5.48 |
6.24 |
4.86 |
5.86 |
7.90 |
|
| Trak2 |  |
NM_172406 |
trafficking protein, kinesin binding 2 (Trak2), mRNA [NM_172406] |
KLA | .94 |
1.01 |
1.01 |
.90 |
.86 |
.85 |
.98 |
| ATP | 1.05 |
1.04 |
1.02 |
.95 |
1.07 |
1.14 |
1.01 |
| KLA/ATP | 1.04 |
.93 |
.84 |
.79 |
.80 |
.95 |
.93 |
|
: View data/graphs for replicates
ATP
ATP+KLA